Trials / Terminated
TerminatedNCT05516875
Open-Label Extension Study of ASTORIA
Open-Label Extension Study of JM-010 in Parkinson's Disease Patients With Dyskinesia
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Contera Pharma A/S · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This current open-label extension (OLE) study (JM-010CS-OL) will explore the safety and tolerability of long-term administration of JM-010 of patients who completed 12-week treatment of Phase 2 (JM-010CS03) study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JM-010 | JM-010 |
Timeline
- Start date
- 2024-01-19
- Primary completion
- 2024-05-22
- Completion
- 2024-06-27
- First posted
- 2022-08-26
- Last updated
- 2024-10-15
Locations
2 sites across 2 countries: Italy, Spain
Source: ClinicalTrials.gov record NCT05516875. Inclusion in this directory is not an endorsement.